Click on image to view larger version.

Figure 1 Glycoprotein Ib–Kozak sequence genotype predicts increased relative risk for the 30-day composite end point after percutaneous transluminal coronary angioplasty (PTCA), but not after directional coronary atherectomy (DCA) or stenting. The figure shows relative risks for the GP Ib–Kozak sequence (C/C + C/T) genotype, with 95% confidence intervals (CI) adjusted for common risk factors, procedural determinants and indicators of procoagulant activation and endothelial function (see text).